IGC Pharma CEO’s RSU Grant Signals Commitment Amid Alzheimer’s Trial & Market Access Challenges
IGC Pharma’s CEO insider activity and RSU grant reveal a long‑term incentive strategy that could boost investor confidence, while the company’s Alzheimer’s pipeline and market‑access focus highlight its competitive positioning and financing needs.
4 minutes to read